The World Lupus Federation (WLF) today released new global survey results on public awareness, attitudes, and perceptions of ...
May is Lupus Awareness Month – a time when the Lupus Foundation of America (LFA) and the global lupus community come together ...
Throughout the month of May, the Lupus Foundation of America is encouraging people living with lupus, friends, family members and partners to be loud and use their voices more than ever before to Make ...
Today, Merck KGaA, Darmstadt, Germany, whose U.S. healthcare arm is EMD Serono, announced that the first trial participant ...
The U.S. Food & Drug Administration (FDA) has granted approval for subcutaneous administration of anifrolumab (SAPHNELO) for ...
In a new analysis of Phase 2 and 3 anifrolumab (Saphnelo®) clinical trial data, researchers found that the SLE Disease ...
A new study is advancing the understanding of lupus nephritis, (LN, lupus-related kidney disease), identifying a microbiome-associated disease pathway. The pathway was found to be associated with ...
A new study is advancing the understanding of lupus nephritis, (LN, lupus-related kidney disease), identifying a ...
Lupus advocates are the engine behind everything we do at the Lupus Foundation of America. Our advocates have pushed forward policy change on a massive scale and have generated more than $262 million ...
Identifying and addressing disparities among people living with lupus ensures communities with the highest burden of disease, like racial and ethnic minorities, receive equitable opportunities for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results